Screener
Eligibility screening
Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents
120 US sites in AL, AR, AZ, CA +32
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.